{"id":26439,"date":"2023-11-27T10:19:46","date_gmt":"2023-11-27T15:19:46","guid":{"rendered":"https:\/\/www.wellable.co\/blog\/?p=26439"},"modified":"2024-03-20T15:53:03","modified_gmt":"2024-03-20T19:53:03","slug":"ozempic-other-glp-1-drugs-transforming-workplace-weight-management","status":"publish","type":"post","link":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/","title":{"rendered":"Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management"},"content":{"rendered":"\n<p>Ozempic (semaglutide), once exclusive to diabetes care, has unexpectedly gained fame for its weight loss effects, sparking interest in similar drugs like Wegovy, Mounjaro, and Zepbound. While Ozempic and Mounjaro are intended for diabetes management, Wegovy and Zepbound treat obesity and related conditions like high blood pressure.<\/p>\n\n\n\n<p>The drugs\u2019 popularity has raised ethical questions, ignited medical debates, and brought about financial implications for healthcare. Understanding their implications is essential for employers to make informed decisions and promote lasting employee health.<\/p>\n\n\n<div style=\"border: 1px solid rgb(0 0 0 \/ 0.1); padding: 25px 25px 10px; border-radius: 8px; box-shadow: 0 4px 6px -1px rgb(0 0 0 \/ 0.1), 0 2px 4px -2px rgb(0 0 0 \/ 0.1);\">\n<h3 id=\"h-pressed-for-time-here-s-a-quick-summary\" class=\"wp-block-heading nitoc\">Pressed for time? Here\u2019s a quick summary\u2026<\/h3>\n<ul>\n<li><strong><span class=\"TextRun SCXW180353673 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">The <\/span><span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">r<\/span><span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">ise<\/span> <span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">o<\/span><span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">f <\/span><span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">Ozempic:<\/span><\/span><\/strong><span class=\"TextRun SCXW180353673 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"> <span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">Initially developed for diabetes, Ozempic gained fame for its weight loss benefits, leading to the approval of <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">Wegovy<\/span> <span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">and <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">Zepbound<\/span> <span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">for obesity treatment. <\/span><span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">Their celebrity-driven fame raises access issues for diabetes patients<\/span><span class=\"NormalTextRun SCXW180353673 BCX0\" data-ccp-parastyle=\"heading 4\">.<\/span><\/span><\/li>\n<li><strong><span class=\"TextRun SCXW93916905 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">Benefits<\/span><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\"> and risks<\/span><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">:<\/span> <\/span><\/strong><span class=\"TextRun SCXW93916905 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SpellingErrorV2Themed SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">Semaglutide<\/span><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\"> helps individuals with Type 2 diabetes <\/span><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">maintain<\/span><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\"> glycemic control and offers weight loss potential comparable to bariatric surgery, reducing cardiovascular disease risks.<\/span> <span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">However,<\/span><\/span> <span class=\"TrackChangeTextInsertion TrackedChange SCXW93916905 BCX0\"><span class=\"TextRun SCXW93916905 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">u<\/span><\/span><\/span><span class=\"TextRun SCXW93916905 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">sers <\/span><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">with diabetes <\/span><span class=\"NormalTextRun SCXW93916905 BCX0\" data-ccp-parastyle=\"heading 4\">may experience nausea, excessive thirst, muscle loss (a concern for those aged 65+), and in rare cases, life-threatening intestinal blockage (ileus).<\/span><\/span><\/li>\n<li><strong><span class=\"TextRun SCXW5074662 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">Health <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">p<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">lan <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">s<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">trategies<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">:<\/span><\/span><\/strong><span class=\"TextRun SCXW5074662 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"> <span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">Coverage strategies <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">for Ozempic <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">include <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">selective coverage<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\"> (<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">limited <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">to individuals with diabetes<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">),<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\"> stringent prerequisites<\/span> <span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">for eligibility<\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">, and <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">comprehensive <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">plans covering <\/span><span class=\"NormalTextRun SCXW5074662 BCX0\" data-ccp-parastyle=\"heading 4\">both diabetes and weight loss.<\/span><\/span><\/li>\n<li><strong><span class=\"TextRun SCXW170036308 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">S<\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">ustainable <\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">s<\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">olution<\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">s<\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">:<\/span><\/span><\/strong><span class=\"TextRun SCXW170036308 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"> <span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">H<\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">olistic wellness programs <\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">that encompass various aspects of well-being <\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">support <\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">sustainable weight management<\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\"> and <\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">overall <\/span><span class=\"NormalTextRun SCXW170036308 BCX0\" data-ccp-parastyle=\"heading 4\">employee health.<\/span><\/span><\/li>\n<\/ul>\n<\/div>\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-the-rise-of-ozempic-wegovy-for-weight-loss\">The Rise Of Ozempic &amp; Wegovy For Weight Loss<\/h2>\n\n\n\n<p>What began as a diabetes treatment has transformed into a sensation, capturing the attention of celebrities, tech titans, and TikTok influencers. <strong>How did Ozempic become a pop culture phenomenon and a perceived &#8220;wonder drug&#8221;?<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-fda-approval-spark-of-popularity\">FDA Approval &amp; Spark Of Popularity<\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"941\" src=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Diabetes-cuate-e1701097579600-1024x941.png\" alt=\"FDA Approval &amp; Spark Of Popularity\" class=\"wp-image-26492\" style=\"width:322px;height:auto\" srcset=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Diabetes-cuate-e1701097579600-1024x941.png 1024w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Diabetes-cuate-e1701097579600-300x276.png 300w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Diabetes-cuate-e1701097579600-768x705.png 768w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Diabetes-cuate-e1701097579600-1536x1411.png 1536w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Diabetes-cuate-e1701097579600.png 1720w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>Ozempic, developed by Novo Nordisk, received FDA approval for diabetes in 2017. Following the successful results of the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program, the FDA <a href=\"https:\/\/www.prnewswire.com\/news-releases\/novo-nordisk-receives-fda-approval-for-wegovy-to-treat-adults-with-obesity-based-on-unprecedented-efficacy-for-a-prescription-medicine-in-clinical-trials-301306246.html#:~:text=The%20FDA%20approval%20of%20Wegovy%20%E2%84%A2%20was%20based,phase%203a%20clinical%20trials%20involving%20approximately%204%2C500%20patients.\" target=\"_blank\" rel=\"noreferrer noopener\">approved<\/a> its higher-dose variant, Wegovy, for obesity treatment. This boosted these drugs\u2019 profiles for weight loss effectiveness.<\/p>\n\n\n\n<p>In parallel, Eli Lilly introduced its GLP-1 (Glucagon-Like Peptide-1) receptor agonists\u2014Mounjaro, approved in 2022 for type 2 diabetes, and Zepbound, approved for weight loss as of November 8, 2023. Both contain tirzepatide, which targets two hormones, potentially increasing their effectiveness for glucose control and weight loss.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ozempic-celebrity-endorsements-a-tiktok-sensation\">#Ozempic: Celebrity Endorsements &amp; A TikTok Sensation<\/h3>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">Hey, <a href=\"https:\/\/twitter.com\/elonmusk?ref_src=twsrc%5Etfw\">@elonmusk<\/a> what\u2019s your secret? You look awesome, fit, ripped &amp; healthy. Lifting weights? Eating healthy? <a href=\"https:\/\/t.co\/mYeOUOLvgH\">pic.twitter.com\/mYeOUOLvgH<\/a><\/p>&mdash; Eva McMillan \u2665\ufe0f (@EvasTeslaSPlaid) <a href=\"https:\/\/twitter.com\/EvasTeslaSPlaid\/status\/1576189386030743552?ref_src=twsrc%5Etfw\">October 1, 2022<\/a><\/blockquote><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<figure class=\"wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">And Wegovy<\/p>&mdash; Elon Musk (@elonmusk) <a href=\"https:\/\/twitter.com\/elonmusk\/status\/1576367983051489281?ref_src=twsrc%5Etfw\">October 2, 2022<\/a><\/blockquote><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<p><a href=\"https:\/\/www.wellable.co\/blog\/amazing-and-terrible-what-its-like-to-work-with-elon-musk\/\" target=\"_blank\" rel=\"noreferrer noopener\">Elon Musk&#8217;s<\/a> public endorsement of Wegovy for his weight loss, along with celebrities like Andy Cohen, amplified the drug&#8217;s popularity. Even within private chats, actors and producers have been &#8220;<a href=\"https:\/\/variety.com\/2022\/film\/actors\/weight-loss-ozempic-semaglutide-hollywood-1235361465\/\" target=\"_blank\" rel=\"noreferrer noopener\">quietly singing the drug&#8217;s praises.<\/a>\u201d TikTok is abuzz with the hashtag #Ozempic, collecting over 273 million views, as users share their astonishment at their weight loss results and swap stories about Ozempic\u2019s side effects.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-demand-consequences\">Demand &amp; Consequences<\/h3>\n\n\n\n<p>The allure of Ozempic and similar \u2018wonder drugs\u2019 have spiked the demand for prescription weight loss medications. Telehealth companies have boosted this by increasing accessibility through online prescriptions. However, the explosive demand for Ozempic and Mounjaro has created shortages for diabetes patients, leaving them scrambling for alternatives.<\/p>\n\n\n\n<div class=\"mb-4\" style=\"border-radius: 15px; background-color: #1b1d35; border: 1px solid #0a0a13; color: #fff; padding: 20px\"><strong><p style=\"color:#fff!important;text-align: center;\">&#8220;We\u2019re getting messages daily about patients not being able to get their own medication. It\u2019s been tough for patients and providers alike.&#8221;<\/p> <\/strong>\n<p style=\"color:#fff!important;text-align: center;\"><em>Dr. Disha Narang, endocrinologist &amp; Director of Obesity Medicine at<br>Northwestern Medicine, Lake Forest Hospital<\/em><\/p>\n<\/div>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"economic-growth\"><strong>Economic Growth&nbsp;<\/strong>&nbsp;<\/h3>\n\n\n\n<p>While the heightened demand for GLP-1s poses accessibility challenges, <a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/weight-loss-drugs-could-boost-us-gdp-by-1-coming-years-goldman-says-2024-02-22\/\" target=\"_blank\" rel=\"noreferrer noopener\">studies<\/a> suggest that their widespread use could significantly boost the US economy. For instance, with 30 million users of weight-loss drugs, the GDP could increase by 0.4%, potentially reaching 1% with 60 million users. This potential for economic improvement is especially relevant given the obesity challenge in the US.\u00a0<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-potential-benefits-risks-of-ozempic-sister-drugs\">Potential Benefits &amp; Risks Of Ozempic &amp; Sister Drugs<\/h2>\n\n\n\n<p>Ozempic, Wegovy, Mounjaro, and Zepbound, despite their endorsements and social media buzz, come with both benefits and risks. Individuals and healthcare providers must carefully consider these drugs\u2019 implications for informed decision-making.<\/p>\n\n\n\n<div class=\"mb-4\" style=\"border-radius: 15px; background-color: #fce8d6; color: #1b1d35; padding: 20px;\"><strong>Important Note: <\/strong><em>The benefits and risks discussed are based on studies involving people with diabetes, obesity, or weight-related conditions. The impact of these drugs on those at a healthy weight remains unclear and needs more research.<\/em><\/div>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-potential-benefits\">Potential Benefits<\/h3>\n\n\n\n<ul>\n<li><strong>Blood sugar regulation: <\/strong>Semaglutide helps lower blood sugar and regulate insulin, critical for Type 2 diabetes management.<\/li>\n\n\n\n<li><strong>Effective weight loss: <\/strong>Semaglutide mimics a satiety hormone. This prompts the stomach to empty slowly, resulting in body weight reductions of <a href=\"https:\/\/www.barrons.com\/articles\/wegovy-ozempic-obesity-drugs-healthcare-system-20307eea\" target=\"_blank\" rel=\"noreferrer noopener\">up to 20%<\/a>, comparable to bariatric surgery. This makes it a powerful drug for those dealing with obesity, who often face various health complications.<\/li>\n\n\n\n<li><strong>Reduced risk of cardiovascular disease:<\/strong> Weight loss achieved with these medications can reduce the risks of heart attack, stroke, and other cardiovascular diseases.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-potential-risks\">Potential Risks<\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" width=\"1024\" height=\"853\" src=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Tiny-depressed-woman-with-anxiety-sitting-on-large-pill-1024x853.jpg\" alt=\"Potential Risks\" class=\"wp-image-26491\" style=\"width:305px;height:auto\" srcset=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Tiny-depressed-woman-with-anxiety-sitting-on-large-pill-1024x853.jpg 1024w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Tiny-depressed-woman-with-anxiety-sitting-on-large-pill-300x250.jpg 300w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Tiny-depressed-woman-with-anxiety-sitting-on-large-pill-768x640.jpg 768w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Tiny-depressed-woman-with-anxiety-sitting-on-large-pill-1536x1280.jpg 1536w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Tiny-depressed-woman-with-anxiety-sitting-on-large-pill-2048x1706.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<ul>\n<li><strong>Nausea &amp; discomfort: <\/strong>Some users experience nausea when they first start using Ozempic, causing initial discomfort but usually subsiding overtime.<\/li>\n\n\n\n<li><strong>Excessive thirst &amp; appetite suppression: <\/strong>Ozempic<strong> <\/strong>often increases thirst, a trade-off for its appetite-suppressing effects. While a reduced appetite aligns with the weight loss goals of many users, some people may experience malnourishment if their urge to eat is diminished. Individuals on this medication must receive proper nutrition guidance, and in extreme cases, discontinue its use.<\/li>\n\n\n\n<li><strong>Long-term muscle loss:<\/strong> <a href=\"https:\/\/fortune.com\/well\/2023\/09\/27\/weight-loss-drugs-ozempic-wegovy-risks-for-people-over-65\/\" target=\"_blank\" rel=\"noreferrer noopener\">Muscle loss<\/a> can occur while on GLP-1 medications. This particularly impacts those aged 65 and above, as it can be detrimental to strength and mobility and escalate the risk of falls and injuries.<\/li>\n<\/ul>\n\n\n\n<div class=\"mb-4\" style=\"border-radius: 15px; background-color: #1b1d35; border: 1px solid #0a0a13; color: #fff; padding: 20px\"><strong><em><p style=\"color:#fff!important;text-align: center;\">&#8220;Losing muscle mass and strength with aging is a natural phenomenon \u2013 everyone has a threshold where it causes a problem.&#8221;<\/p><\/em><\/strong>\n<p style=\"color:#fff!important;text-align: center;\"><em> &#8211; John Batsis, expert in geriatric medicine &#8211;<\/p><\/em>\n<\/div>\n\n\n\n<ul>\n<li><strong>Intestinal blockage (Ileus): <\/strong>In rare cases, Ozempic has been associated with intestinal blockage, known as <a href=\"https:\/\/www.fiercepharma.com\/pharma\/novo-nordisks-ozempic-gets-label-warning-intestinal-blockage-disorder\" target=\"_blank\" rel=\"noreferrer noopener\">ileus<\/a>. This condition causes drastic increases in intestinal length, which can be life-threatening. The FDA has updated the drug&#8217;s label to include a warning about this risk.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-health-insurance-plans-responses\">Health Insurance Plans\u2019 Responses<\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" width=\"1024\" height=\"705\" src=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/2203_w037_n003_236a_p1_236-1024x705.jpg\" alt=\"Health Insurance Plans\u2019 Responses\" class=\"wp-image-26496\" style=\"width:344px;height:auto\" srcset=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/2203_w037_n003_236a_p1_236-1024x705.jpg 1024w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/2203_w037_n003_236a_p1_236-300x207.jpg 300w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/2203_w037_n003_236a_p1_236-768x529.jpg 768w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/2203_w037_n003_236a_p1_236-1536x1058.jpg 1536w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/2203_w037_n003_236a_p1_236-2048x1410.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>The annual cost of obesity-related illnesses is roughly <a href=\"https:\/\/www.nytimes.com\/2024\/03\/04\/opinion\/ozempic-wegovy-medicare-federal-budget.html?campaign_id=4&amp;emc=edit_dk_20240305&amp;instance_id=116766&amp;nl=dealbook&amp;referringSource=articleShare&amp;regi_id=66937636&amp;segment_id=159873&amp;smid=nytcore-ios-share&amp;te=1&amp;user_id=49a5ea144a49270344b3345d2df7690f\" target=\"_blank\" rel=\"noreferrer noopener\">$210 billion<\/a> and rising. With more than 40% of Americans classified as obese\u2014a figure projected to reach nearly 50% by 2030\u2014the demand for effective treatments like GLP-1 drugs is growing.&nbsp;&nbsp;<\/p>\n\n\n\n<p>However, these drugs are costly, and their long-term use is necessary to maintain weight loss, posing challenges for sustainable healthcare financing.&nbsp;<\/p>\n\n\n\n<p>Furthermore, <a href=\"https:\/\/www.wellable.co\/blog\/self-funded-vs-fully-insured-health-plans-employee-wellness-perspective\/\" target=\"_blank\" rel=\"noreferrer noopener\">health insurance plans<\/a> face the dilemma of integrating drugs that were initially designed for diabetes into weight management coverages. Some have historically hesitated to cover Wegovy, referring to it as a \u201cvanity drug.\u201d&nbsp; <strong>Potential coverage strategies include:<\/strong>&nbsp;<\/p>\n\n\n\n<ul>\n<li><strong>Selective coverage: <\/strong>Insurers distinguish between diabetes management and weight loss needs, ensuring appropriate patient access while managing the demand for their weight loss use.<\/li>\n\n\n\n<li><strong>Stringent coverage: <\/strong>Insurers may require patients to meet specific conditions or try cheaper alternatives before gaining access to GLPs, controlling utilization and expenses.<\/li>\n\n\n\n<li><strong>Comprehensive guidelines:<\/strong> Some might develop guidelines addressing the requirements of both diabetes management and weight loss, recognizing the potential for broader health benefits linked to weight loss. This may lead to long-term cost savings.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ama-s-call-for-inclusive-coverage\">AMA\u2019s Call for Inclusive Coverage<\/h3>\n\n\n\n<p>In recent developments, the American Medical Association (AMA) has officially recommended that health insurers <a href=\"https:\/\/www.ama-assn.org\/press-center\/press-releases\/ama-urges-insurance-coverage-parity-emerging-obesity-treatment-options#:~:text=Nov%2014%2C%202023&amp;text=In%20response%2C%20physicians%20and%20medical,exclusions%20or%20additional%20carve%2Douts.\" target=\"_blank\" rel=\"noreferrer noopener\">cover FDA-approved weight loss medications<\/a>, including GLP-1 agonists like Wegovy and Ozempic. This highlights a significant coverage issue: while federal regulations currently prevent Medicare from covering these medications for weight loss, employer health plans have adopted varying stances. Approximately 75% of employer plans cover these drugs for diabetes treatment, but only 25% extend this coverage for weight loss, underscoring a gap in patient access to these treatments.<\/p>\n\n\n\n<p>Insurance policies will continue to adapt to the evolving use of GLP drugs and ongoing data on their benefits and cost-effectiveness.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"solutions-for-sustainable-obesity-management\">Solutions For Sustainable Obesity Management<\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-1024x1024.jpg\" alt=\"Solutions For Sustainable Obesity Management\" class=\"wp-image-26602\" style=\"width:308px;height:auto\" srcset=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-1024x1024.jpg 1024w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-300x300.jpg 300w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-150x150.jpg 150w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-768x768.jpg 768w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-1536x1536.jpg 1536w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-2048x2048.jpg 2048w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/12\/Wavy_Lst-05_Single-04-96x96.jpg 96w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>The <a href=\"https:\/\/www.wellable.co\/blog\/alarming-obesity-rates-caused-by-broken-us-food-system\/\" target=\"_blank\" rel=\"noreferrer noopener\">alarming US obesity rates<\/a> pose a dual challenge for employers, impacting not only employee well-being but also business performance. Studies indicate that obese individuals are less likely to be employed and, when they are, tend to be less productive.&nbsp;&nbsp;<\/p>\n\n\n\n<p>However, addressing this issue with GLP-1 medications introduces new financial considerations. While drugs like Ozempic offer a solution to manage weight and related health issues, they also add a significant expense for employers. For some, Ozempic has become their highest-cost drug\u2014one organization of 5,000 employees reported over <a href=\"https:\/\/www.benefitnews.com\/advisers\/news\/the-employer-cost-of-weight-loss-drugs-ozempic-and-wegovy\" target=\"_blank\" rel=\"noreferrer noopener\">$100,000<\/a> in Ozempic expenses in one month. &nbsp;<\/p>\n\n\n\n<p>Therefore, employers are at a crossroads: they\u2019re determined to enhance <a href=\"https:\/\/www.wellable.co\/blog\/importance-of-employee-health-in-the-workplace\/\" target=\"_blank\" rel=\"noreferrer noopener\">employee health<\/a> and productivity, but they must also manage growing healthcare costs. <strong>How can organizations deliver effective care while maintaining cost control?<\/strong>&nbsp;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-connecticut-s-innovative-approach\">Connecticut&#8217;s Innovative Approach<\/h3>\n\n\n\n<p><a href=\"https:\/\/www.politico.com\/news\/2023\/11\/15\/weight-loss-drugs-00127203\" target=\"_blank\" rel=\"noreferrer noopener\">Connecticut\u2019s state employee health plan<\/a>, covering 265,000 employees, faced rising costs due to the popularity of weight loss medications like Ozempic and Wegovy. Instead of eliminating coverage, plan members seeking these drugs must now participate in a clinical lifestyle management program called Flyte before prescriptions are considered. Flyte offers online tools for weight management, personalized care plans, and may lead to drug prescriptions, which are covered by the plan. Organizations may adopt a similar approach to manage costly yet effective treatments.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategies-for-employers\">Strategies For Employers<\/h3>\n\n\n\n<p>It\u2019s critical to recognize that weight management isn\u2019t a one-and-done intervention. It requires a comprehensive set of ongoing initiatives that contribute to a healthy lifestyle.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"528\" height=\"437\" src=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/ResourceBlog-Graphic-24-e1701097659126.png\" alt=\"Strategies For Employers\" class=\"wp-image-26489\" style=\"width:270px;height:auto\" srcset=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/ResourceBlog-Graphic-24-e1701097659126.png 528w, https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/ResourceBlog-Graphic-24-e1701097659126-300x248.png 300w\" sizes=\"(max-width: 528px) 100vw, 528px\" \/><\/figure><\/div>\n\n\n<ol start=\"1\">\n<li><strong>Holistic wellness programs: <\/strong>Wellness programs, like <a href=\"https:\/\/www.wellable.co\/wellness-platform\/\" target=\"_blank\" rel=\"noreferrer noopener\">Wellable\u2019s<\/a> integrate physical activity, nutrition, sleep, <a href=\"https:\/\/www.wellable.co\/employee-wellness-challenges\/stress-less-challenge\" target=\"_blank\" rel=\"noreferrer noopener\">stress management,<\/a> and more to enhance overall well-being and support sustainable weight reduction. It\u2019s crucial that these programs integrate physical activities like strength training and resistance exercises to preserve muscle mass, which plays a key role in health and longevity.<\/li>\n\n\n\n<li><strong>Drug eligibility:<\/strong> Employers may consider tying eligibility for Ozempic and similar drugs to participation in wellness programs, similar to Connecticut\u2019s Flyte program. While the intention is to encourage positive lifestyle changes, it&#8217;s equally important to uphold ethical standards by prioritizing patient autonomy and equitable access. Exemptions should be available for those who can&#8217;t participate due to work schedules, family responsibilities, or health reasons. Providing diverse program options that suit different needs ensures inclusivity.<\/li>\n<\/ol>\n\n\n\n<div class=\"mb-4\" style=\"border-radius: 15px; background-color: #fce8d6; color: #1b1d35; padding: 20px;\"><strong>Important Note:<\/strong><em> This approach is somewhat analogous to practices where insurance premiums vary based on participation. While it may raise ethical questions, the goal is to promote healthier choices without compromising fundamental medication access rights. Ultimately, such policies should not restrict essential medication access.<\/em><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div class=\"mb-4\" style=\"border-radius: 15px; background-color: #1b1d35; border: 1px solid #0a0a13; color: #fff; padding: 20px\"><strong><em><p style=\"color:#fff!important\">&#8220;This is not meant to be a medication to take off your last five or 10 pounds to get ready for an event or something like that&#8230;When we think about weight management, we\u2019re thinking about the next 25 years of someone\u2019s life.&#8221;<\/p><\/em><\/strong>\n<p style=\"color:#fff!important\"><em>&#8211; Dr. Disha Narang, endocrinologist &#038; Director of Obesity Medicine at Northwestern Medicine,<br>Lake Forest Hospital<\/em><\/p>\n<\/div>\n\n\n\n<p>3. <strong>Health coaching: <\/strong><a href=\"https:\/\/www.wellable.co\/blog\/the-power-of-health-coaching-at-work\/\" target=\"_blank\" rel=\"noreferrer noopener\">Health coaching<\/a> can supplement wellness programs or act as a stand-alone initiative, providing personalized guidance and support for achieving lasting weight loss. This can complement the use of medication while aligning with the broader goal of improving employee health and managing healthcare costs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ozempic: From diabetes treatment to a weight loss &#8216;wonder drug&#8217;. Explore its rise, insurance strategies, and solutions for employers to support weight management.<\/p>\n","protected":false},"author":1,"featured_media":26518,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.6 (Yoast SEO v22.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management | Wellable<\/title>\n<meta name=\"description\" content=\"Ozempic: From diabetes treatment to a weight loss &#039;wonder drug&#039;. Explore its rise, insurance strategies, and solutions for employers to support weight management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management | Wellable\" \/>\n<meta property=\"og:description\" content=\"Ozempic: From diabetes treatment to a weight loss &#039;wonder drug&#039;. Explore its rise, insurance strategies, and solutions for employers to support weight management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/\" \/>\n<meta property=\"og:site_name\" content=\"Wellable\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GetWellable\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-27T15:19:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-20T19:53:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Blog-Images-Social-29.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Wellable\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@getwellable\" \/>\n<meta name=\"twitter:site\" content=\"@getwellable\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Wellable\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management | Wellable","description":"Ozempic: From diabetes treatment to a weight loss 'wonder drug'. Explore its rise, insurance strategies, and solutions for employers to support weight management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/","og_locale":"en_US","og_type":"article","og_title":"Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management | Wellable","og_description":"Ozempic: From diabetes treatment to a weight loss 'wonder drug'. Explore its rise, insurance strategies, and solutions for employers to support weight management.","og_url":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/","og_site_name":"Wellable","article_publisher":"https:\/\/www.facebook.com\/GetWellable\/","article_published_time":"2023-11-27T15:19:46+00:00","article_modified_time":"2024-03-20T19:53:03+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Blog-Images-Social-29.png","type":"image\/png"}],"author":"Wellable","twitter_card":"summary_large_image","twitter_creator":"@getwellable","twitter_site":"@getwellable","twitter_misc":{"Written by":"Wellable","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/#article","isPartOf":{"@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/"},"author":{"name":"Wellable","@id":"https:\/\/www.wellable.co\/blog\/#\/schema\/person\/f7c042b5403e555f4cd545a365023e71"},"headline":"Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management","datePublished":"2023-11-27T15:19:46+00:00","dateModified":"2024-03-20T19:53:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/"},"wordCount":1795,"publisher":{"@id":"https:\/\/www.wellable.co\/blog\/#organization"},"image":{"@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Are-Ozempic-Other-Weight-Loss-\u2018Wonder-Drugs-The-Ultimate-Weight-Loss-Solutions-Or-Just-Hype.png","articleSection":["Facts and Research"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/","url":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/","name":"Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management | Wellable","isPartOf":{"@id":"https:\/\/www.wellable.co\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/#primaryimage"},"image":{"@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Are-Ozempic-Other-Weight-Loss-\u2018Wonder-Drugs-The-Ultimate-Weight-Loss-Solutions-Or-Just-Hype.png","datePublished":"2023-11-27T15:19:46+00:00","dateModified":"2024-03-20T19:53:03+00:00","description":"Ozempic: From diabetes treatment to a weight loss 'wonder drug'. Explore its rise, insurance strategies, and solutions for employers to support weight management.","breadcrumb":{"@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/#primaryimage","url":"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Are-Ozempic-Other-Weight-Loss-\u2018Wonder-Drugs-The-Ultimate-Weight-Loss-Solutions-Or-Just-Hype.png","contentUrl":"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2023\/11\/Are-Ozempic-Other-Weight-Loss-\u2018Wonder-Drugs-The-Ultimate-Weight-Loss-Solutions-Or-Just-Hype.png","width":650,"height":500,"caption":"Are Ozempic & Other Weight-Loss \u2018Wonder Drugs\u2019 The Ultimate Weight Loss Solutions, Or Just Hype?"},{"@type":"BreadcrumbList","@id":"https:\/\/www.wellable.co\/blog\/ozempic-other-glp-1-drugs-transforming-workplace-weight-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.wellable.co\/blog\/"},{"@type":"ListItem","position":2,"name":"Ozempic, Other GLP-1 Drugs Transforming Workplace Weight Management"}]},{"@type":"WebSite","@id":"https:\/\/www.wellable.co\/blog\/#website","url":"https:\/\/www.wellable.co\/blog\/","name":"Wellable","description":"Latest Research &amp; News in Wellness","publisher":{"@id":"https:\/\/www.wellable.co\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.wellable.co\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.wellable.co\/blog\/#organization","name":"Wellable","url":"https:\/\/www.wellable.co\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.wellable.co\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2022\/06\/favicon-wellable.webp","contentUrl":"https:\/\/www.wellable.co\/blog\/wp-content\/uploads\/2022\/06\/favicon-wellable.webp","width":155,"height":157,"caption":"Wellable"},"image":{"@id":"https:\/\/www.wellable.co\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/GetWellable\/","https:\/\/twitter.com\/getwellable","https:\/\/www.linkedin.com\/company\/wellable-inc-\/","https:\/\/www.youtube.com\/channel\/UCtTLlvZR-tKRBcb32l-rFXg"]},{"@type":"Person","@id":"https:\/\/www.wellable.co\/blog\/#\/schema\/person\/f7c042b5403e555f4cd545a365023e71","name":"Wellable","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.wellable.co\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/278328db6f4b525c6e46d5d50078b0e6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/278328db6f4b525c6e46d5d50078b0e6?s=96&d=mm&r=g","caption":"Wellable"},"sameAs":["http:\/\/34.168.145.72"],"url":"https:\/\/www.wellable.co\/blog\/author\/wellable-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/posts\/26439"}],"collection":[{"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/comments?post=26439"}],"version-history":[{"count":77,"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/posts\/26439\/revisions"}],"predecessor-version":[{"id":29036,"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/posts\/26439\/revisions\/29036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/media\/26518"}],"wp:attachment":[{"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/media?parent=26439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/categories?post=26439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wellable.co\/blog\/wp-json\/wp\/v2\/tags?post=26439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}